News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive January 5, 2021 Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference Archive November 30, 2020 Deciphera Pharmaceuticals Completes Target Enrollment in the INTRIGUE Phase 3 Clinical Study of QINLOCK® (Ripretinib) in Patients with Second-Line Gastrointestinal Stromal Tumor Archive November 24, 2020 Deciphera Pharmaceuticals, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Archive November 23, 2020 The Boston Globe Names Deciphera a Top Place to Work for 2020 Archive November 11, 2020 Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting Archive November 11, 2020 Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting Archive November 10, 2020 Deciphera Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference Archive November 5, 2020 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results Archive October 28, 2020 Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 5, 2020 Archive September 18, 2020 Deciphera Presents Data from QINLOCK™ (Ripretinib) Program in Patients with Gastrointestinal Stromal Tumor at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
Archive January 5, 2021 Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
Archive November 30, 2020 Deciphera Pharmaceuticals Completes Target Enrollment in the INTRIGUE Phase 3 Clinical Study of QINLOCK® (Ripretinib) in Patients with Second-Line Gastrointestinal Stromal Tumor
Archive November 24, 2020 Deciphera Pharmaceuticals, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
Archive November 11, 2020 Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Archive November 11, 2020 Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Archive November 10, 2020 Deciphera Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
Archive November 5, 2020 Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results
Archive October 28, 2020 Deciphera Pharmaceuticals, Inc. to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 5, 2020
Archive September 18, 2020 Deciphera Presents Data from QINLOCK™ (Ripretinib) Program in Patients with Gastrointestinal Stromal Tumor at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
